Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Carbohydrate doai
Patent
1995-06-05
1998-11-03
Fonda, Kathleen K.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Carbohydrate doai
514 62, 514886, 514887, 536 53, 536 551, 536 552, A61K 31715, C08B 3700
Patent
active
058308822
ABSTRACT:
A combination for administration to a mammal which combination employs a therapeutically effective amount of a medicinal and/or therapeutic agent to treat a disease or condition and an amount of hyaluronic acid and/or salts thereof and/or homologues, analogues, derivatives, complexes, esters, fragments and subunits of hyaluronic acid sufficient to facilitate the agent's penetration through the tissue (including scar tissue) at the site to be treated, through the cell membranes into the individual cells to be treated.
REFERENCES:
patent: 2583096 (1952-01-01), Hadidian et al.
patent: 3436454 (1969-04-01), Nouvel
patent: 3887703 (1975-06-01), Manoussos et al.
patent: 4141973 (1979-02-01), Balazs
patent: 4272522 (1981-06-01), Balazs
patent: 4582865 (1986-04-01), Balazs et al.
patent: 4636524 (1987-01-01), Balazs et al.
patent: 4711780 (1987-12-01), Fahim
patent: 4716224 (1987-12-01), Sakurai et al.
patent: 4725585 (1988-02-01), Wenge et al.
patent: 4736024 (1988-04-01), Della Valle et al.
patent: 4755544 (1988-07-01), Makino et al.
patent: 4795741 (1989-01-01), Leschiner et al.
patent: 4801619 (1989-01-01), Lindblad
patent: 4808576 (1989-02-01), Schultz et al.
patent: 4814176 (1989-03-01), Makino et al.
patent: 4840941 (1989-06-01), Ueno et al.
patent: 4851521 (1989-07-01), della Valle et al.
patent: 4853226 (1989-08-01), Machida et al.
patent: 4937254 (1990-06-01), Sheffield et al.
patent: 4946870 (1990-08-01), Partain, III. et al.
patent: 4957744 (1990-09-01), della Valle et al.
patent: 5053222 (1991-10-01), Takasu et al.
patent: 5137875 (1992-08-01), Tsunenaga et al.
patent: 5166331 (1992-11-01), della Valle
patent: 5385938 (1995-01-01), Yu et al.
"The Merck Manual of Diagnosis and Therapy", Fifteenth Edition, R. Berkow, ed., Merck Sharp & Dohme Research Laboratories, Rahway, New Jersey, 1987.
"Webster's Ninth New Collegiate Dictionary", F. C. Mish, ed., Merriam-Webster Inc., Springfield, Massachusetts, 1990.
Blakeslee, S., "Solid cores of tumors keeping out best drugs", Jul. 8, 1989 edition of The Glove and Mail, Toronto, Ont., p. D4.
Harrison, P., "Toxic drug tamed but still potent", Ontario Medicine, vol. 8, No. 16, Aug. 21, 1989, p. 1.
The Merck Index. Eleventh Edition, Centennial Edition, Hyaluronic Acid formulation, pp. 751-752.
Braun, DP et al., "Modulation of Immunity in Cancer Patients by Prostagladin Antagonists", Immunity to Cancer II, 1989, pp. 439-448, Alan R. Liss, Inc.
Goodwin, J.S., Prostaglandin E and Cancer Growth: Potential for Immunotherapy with Prostaglandin Synthesis Inhibitors, Augmentive Agents in Cancer Therapy, Raven Press, New York (1981), pp. 393-415.
Asculai, Dr. S., "Inactivation of Herpes Simplex Viruses by Nonionic Surfctants", Antimicobial Agents and Chemotherapy, Apr. 1978, pp. 686-690.
Sneader, W.E., Chemical Abstracts, vol. 76, No. 10, Possible Mechanism for Action of DMSO on Percutaeous absorption. J. Pharm. Pharmacol, 1971, 23 (Supp).
International Preliminary Examination Report for PCT/CA90/00306 and attachement substitute claims, no publication date.
Alaverdyan et al., "Effect of hyaluronidase, hyaluoronic acid, and some other substances on postraditional experimental bacteriemia".
Bulletin of Experimental Biology & Medicine 1967: 64(9):967-969.
Balazs et al. "The rheoiogical properties and biological funtion of hyaluronic acid", Chem. and Mol. Biol. of the Intercellular Matrix, vol. 3, 1970, pp. 1241-1253.
Balezs E.A. et al, "Hyaluronic acid: Its structure and use", Cosmetics & Toiletries, Polymers in Cosmetics 1984; 99: 65-72.
Camber O. et al, "Diffusion of some low molecular weight compounds in sodium hyaluronate", Acta Pharmaceutica Suecica 1985; 22(6): 315-320.
Camber O. et al. "Influence of sodium hyaluronate on the meiotic effect of pilocarpine in rabbits", Current Eve Research 1987: 6(6): 779-784.
Chang S-C. "Prodrug and vehicle approaches to improve the therapeutic index of topically applied timolol in the pigmented rabbit", Dissertation Abstracts International 1988: 49(2): 367-B.
Cravioto R O et al, Effect of Precipitates Formed by Insulin with Hyaluronic Acid and Mucoid from Vitreous Humor in Depressing Blood-Sugar Levels Science (1950); vol. 111: 520-521.
Gieldanowski J et al, "Studies on immunosuppresive and anti-inflammatory effects of adriamycin", Arch. Immunol. Ther. Exp. (1980); 28(3): 439-446.
Hassan, H.G., et al., "Effects of adjuvants to local anaesthetics on their duration", Acta Anaesthesiol Scand 1985; 29: 384-388.
Hurd, E.R., "Immunosuppressive and antiinflammatory properties of cyclophosphamide, azathioprine and methotrexate", Arthritis and Rheumatism (1973 Jan./Feb.); 16(1): 84-88.
Idson B, "Polymers in skin cosmetics", Cosmetics & Toiletries 1988; 103: 63-68.
Johansson A. et al, "Effects of adjuvants to local anaesthetics on their duration", Acta Anaesthesiol Scand 1985; 29: 736-738.
Kalbhen D.A., The inhibitory effects of steroidal and non-steroidal antirheumatic drugs on articular cartilage in osteroarthrosis and its counteraction by a biological GAG-peptide complex (Rumalon.RTM.), Z. Rheumatol (1982): 41: 202-211.
Katsu M. et al., "Significance and clinical use of non-steroid anti-inflammatory drugs as substitutes for steroids in steroid dependence", Nippon Rinsho (1986 Jan) 26(1): 89-95.
Kreis H et al, "Nonsteroid antiinflammatory agents as a substitute treatment for steroids in ATGAM-treated cadaver kidney recipients" Transplantation (1984 Feb.); 37(2): 139-145.
McIlwraith W, "Current concepts in equine degenerative joint disease", Journal of the Am. Veterinary Medical Assoc. 1982; Feb. 1. vol. 180: 239-250.
Mizushima Y., "Possibility of non-steroid anti-inflammatory drugs as a substitute for steroids-analysis of the present situation and demands for the future", Nippon Rinsho (Jan. 1986); 26(1): 61-65.
Nizolek D.J.H. et al, "Corticosteroid and hyaluronic acid treatments in equine degenerative joint disease: A Review" The Cornell Veterinarian 1981: 7(4): 355-375.
Pigman W et al, "Acide hyaluronique et facteurs de permeabilite tissulaire" Bull. Soc. Chim. Biol. 1963; 45(2-3); 185-202.
Pruett RC, et al, "Hyaluronic acid vitreious substitue", In: Vitreous Surgery and Advances in Fundus Diagnosis and Treatment, H. McKenzie Freeman et al. Editors, Appleton-Century-Crofts, 1977; Chapter 55, pp. 433-444.
Reim M et al, "Surgical procedures in the treatment of most severe eye burns" Acta Ophthalmologica 1989-Supplemenrum 192; 67: 47-54.
Rydell N et al, "Effect of intra-articular injection of hyaluronic acid on the clinical symptons of osteroarhritis and on gradulation tissue formation" Clinical Orthopaedics and Related Research 1971; 80 (Oct.): 25-29.
Saba P. et al, "Investigation of antihyperlipemic activity of an association of clofibrate and extractive mucopolysaccharide complex", Current Therapeutic Research 1978: 23(4): 455-463.
Stegmann R et al, "Use of sodium hyaluronate in sever penetrating ocular trauma" Acta Ophthalmol, 1986; 18: 9-13.
Trabucchi E et al, "Prevention of wound dehiscense in severely obese patients with jejuno-ileal by-pass: the role of hyaluronic acid"0 Pharmatherapeutica 1988; 5(4): 233-239.
Sertoli P et al., L'acido jaluronico, per uso topico, nella cura della ulcere trofocircolatorie degli arti inferiori (Comunicazioni) Giornale Italiano di Dermatologia 1970; 45(8): 468-471.
Walther M, "The Prevention of Strine Cutis Distansae During Pregnancy", Minerva Ginecologica (1981) Vo. 33: 497-499.
Weirich E G et al, "Dermatopharmacology of salicyclic acid. III. Topical contra-inflammatory effects of salicyclic acid and other drugs in animal experiments", Dermatologica (1976); 152(2): 87-99.
Alaverdyan MI, Ter-Avetisyan AT. Effect of hyaluronidase, hyaluronic acid, and some other substances on postradiational experimental bacteriemai, Bulletin of Experimental Biology and Medicine 1967; 64(9): 967-969.
Balazs EA, Gibbs DA. The rheological properties and biological function of hyaluronic acid. In: Chemistry and Molecular Biology of the Intercellular Matrix. vols. III. New York: Academic Press, 1970. pp. 1241-1253.
Balazs EA, Band P. Hyaluronic acid: Its structure and use. Cosmetics & Toiletries. Po
Asculai Samuel S.
Falk Rudolf Edgar
Fonda Kathleen K.
Hughes Ivor M.
Hughes Neil H.
Hyal Pharmaceutical Corporation
Sarkis Marcelo K.
LandOfFree
Compositions containing a form of hyaluronic acid and a medicina does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions containing a form of hyaluronic acid and a medicina, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions containing a form of hyaluronic acid and a medicina will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-689319